HISTOLOGY AND HISTOPATHOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1203667, encodeId=13d1120366e80, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：太慢了。。。一月投稿，至今仍under review，关键系统日期都不变，感觉编辑没在处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58b11674643, createdName=johnhesion, createdTime=Fri Mar 18 07:11:00 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197349, encodeId=5ff7119e34928, content=偏重的研究方向：肿瘤 经验分享：2个多月了，一点动静都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Fri Feb 25 23:21:33 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197326, encodeId=25b6119e32619, content=偏重的研究方向：肿瘤 经验分享：审了快四个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ea93125652, createdName=zzk411, createdTime=Fri Feb 25 22:33:56 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091139, encodeId=fe8b109113943, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091140, encodeId=1574109114096, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009564, encodeId=613710095649e, content=审稿速度:12.0 偏重的研究方向：肿瘤 经验分享：2月16号投稿，6月9号给了一个小修，一个月返修时间。7月5号返修回去，截止到8月19号还是under review.真是慢啊。写了撤稿信，3天了都没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Thu Aug 19 22:14:01 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907652, encodeId=9d7190e652db, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;分子 经验分享：一篇肿瘤相关的miRNA文章，审稿了三个多月悲剧了。。。。貌似不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sun Dec 13 19:20:14 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577096, encodeId=f3ae5e7096dc, content=接收个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLwp1gIfBxH4RibdfveKfd9bff6pU7YZXorDEZ0CJXQOZajYCFzibSNQLnUyDqcTiad7e7QAia6TP2w0A/132, createdBy=1f9d2516382, createdName=124cd967m46(暂无昵称), createdTime=Sun Sep 29 10:57:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572459, encodeId=bb8b5e2459fd, content=***pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, beContent=pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f06f5081805, createdName=绝处逢生, createdTime=Thu Jun 20 00:00:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560632, encodeId=723b56063216, content=现在快了吗啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, beContent=啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9cpyAQZ4bhibVic2UeLIE6m8wtDWI93EYnussrdcmBPwc0LL3UyIKSUGtRMkRL2ibhT93xlC0xCHEQ/132, createdBy=e0621689620, createdName=1de55003m82(暂无匿称), createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]

2022-03-18 johnhesion

审稿速度:12.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：太慢了。。。一月投稿，至今仍under review，关键系统日期都不变，感觉编辑没在处理稿件

42 0

[GetPortalCommentsPageByObjectIdResponse(id=1203667, encodeId=13d1120366e80, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：太慢了。。。一月投稿，至今仍under review，关键系统日期都不变，感觉编辑没在处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58b11674643, createdName=johnhesion, createdTime=Fri Mar 18 07:11:00 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197349, encodeId=5ff7119e34928, content=偏重的研究方向：肿瘤 经验分享：2个多月了，一点动静都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Fri Feb 25 23:21:33 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197326, encodeId=25b6119e32619, content=偏重的研究方向：肿瘤 经验分享：审了快四个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ea93125652, createdName=zzk411, createdTime=Fri Feb 25 22:33:56 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091139, encodeId=fe8b109113943, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091140, encodeId=1574109114096, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009564, encodeId=613710095649e, content=审稿速度:12.0 偏重的研究方向：肿瘤 经验分享：2月16号投稿，6月9号给了一个小修，一个月返修时间。7月5号返修回去，截止到8月19号还是under review.真是慢啊。写了撤稿信，3天了都没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Thu Aug 19 22:14:01 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907652, encodeId=9d7190e652db, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;分子 经验分享：一篇肿瘤相关的miRNA文章，审稿了三个多月悲剧了。。。。貌似不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sun Dec 13 19:20:14 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577096, encodeId=f3ae5e7096dc, content=接收个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLwp1gIfBxH4RibdfveKfd9bff6pU7YZXorDEZ0CJXQOZajYCFzibSNQLnUyDqcTiad7e7QAia6TP2w0A/132, createdBy=1f9d2516382, createdName=124cd967m46(暂无昵称), createdTime=Sun Sep 29 10:57:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572459, encodeId=bb8b5e2459fd, content=***pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, beContent=pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f06f5081805, createdName=绝处逢生, createdTime=Thu Jun 20 00:00:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560632, encodeId=723b56063216, content=现在快了吗啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, beContent=啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9cpyAQZ4bhibVic2UeLIE6m8wtDWI93EYnussrdcmBPwc0LL3UyIKSUGtRMkRL2ibhT93xlC0xCHEQ/132, createdBy=e0621689620, createdName=1de55003m82(暂无匿称), createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]

2022-02-25 1891f95b28m

偏重的研究方向：肿瘤
经验分享：2个多月了，一点动静都没有

47 0

[GetPortalCommentsPageByObjectIdResponse(id=1203667, encodeId=13d1120366e80, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：太慢了。。。一月投稿，至今仍under review，关键系统日期都不变，感觉编辑没在处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58b11674643, createdName=johnhesion, createdTime=Fri Mar 18 07:11:00 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197349, encodeId=5ff7119e34928, content=偏重的研究方向：肿瘤 经验分享：2个多月了，一点动静都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Fri Feb 25 23:21:33 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197326, encodeId=25b6119e32619, content=偏重的研究方向：肿瘤 经验分享：审了快四个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ea93125652, createdName=zzk411, createdTime=Fri Feb 25 22:33:56 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091139, encodeId=fe8b109113943, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091140, encodeId=1574109114096, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009564, encodeId=613710095649e, content=审稿速度:12.0 偏重的研究方向：肿瘤 经验分享：2月16号投稿，6月9号给了一个小修，一个月返修时间。7月5号返修回去，截止到8月19号还是under review.真是慢啊。写了撤稿信，3天了都没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Thu Aug 19 22:14:01 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907652, encodeId=9d7190e652db, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;分子 经验分享：一篇肿瘤相关的miRNA文章，审稿了三个多月悲剧了。。。。貌似不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sun Dec 13 19:20:14 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577096, encodeId=f3ae5e7096dc, content=接收个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLwp1gIfBxH4RibdfveKfd9bff6pU7YZXorDEZ0CJXQOZajYCFzibSNQLnUyDqcTiad7e7QAia6TP2w0A/132, createdBy=1f9d2516382, createdName=124cd967m46(暂无昵称), createdTime=Sun Sep 29 10:57:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572459, encodeId=bb8b5e2459fd, content=***pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, beContent=pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f06f5081805, createdName=绝处逢生, createdTime=Thu Jun 20 00:00:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560632, encodeId=723b56063216, content=现在快了吗啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, beContent=啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9cpyAQZ4bhibVic2UeLIE6m8wtDWI93EYnussrdcmBPwc0LL3UyIKSUGtRMkRL2ibhT93xlC0xCHEQ/132, createdBy=e0621689620, createdName=1de55003m82(暂无匿称), createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]

2022-02-25 zzk411

偏重的研究方向：肿瘤
经验分享：审了快四个月了，还在under review

42 0

[GetPortalCommentsPageByObjectIdResponse(id=1203667, encodeId=13d1120366e80, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：太慢了。。。一月投稿，至今仍under review，关键系统日期都不变，感觉编辑没在处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58b11674643, createdName=johnhesion, createdTime=Fri Mar 18 07:11:00 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197349, encodeId=5ff7119e34928, content=偏重的研究方向：肿瘤 经验分享：2个多月了，一点动静都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Fri Feb 25 23:21:33 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197326, encodeId=25b6119e32619, content=偏重的研究方向：肿瘤 经验分享：审了快四个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ea93125652, createdName=zzk411, createdTime=Fri Feb 25 22:33:56 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091139, encodeId=fe8b109113943, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091140, encodeId=1574109114096, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009564, encodeId=613710095649e, content=审稿速度:12.0 偏重的研究方向：肿瘤 经验分享：2月16号投稿，6月9号给了一个小修，一个月返修时间。7月5号返修回去，截止到8月19号还是under review.真是慢啊。写了撤稿信，3天了都没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Thu Aug 19 22:14:01 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907652, encodeId=9d7190e652db, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;分子 经验分享：一篇肿瘤相关的miRNA文章，审稿了三个多月悲剧了。。。。貌似不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sun Dec 13 19:20:14 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577096, encodeId=f3ae5e7096dc, content=接收个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLwp1gIfBxH4RibdfveKfd9bff6pU7YZXorDEZ0CJXQOZajYCFzibSNQLnUyDqcTiad7e7QAia6TP2w0A/132, createdBy=1f9d2516382, createdName=124cd967m46(暂无昵称), createdTime=Sun Sep 29 10:57:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572459, encodeId=bb8b5e2459fd, content=***pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, beContent=pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f06f5081805, createdName=绝处逢生, createdTime=Thu Jun 20 00:00:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560632, encodeId=723b56063216, content=现在快了吗啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, beContent=啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9cpyAQZ4bhibVic2UeLIE6m8wtDWI93EYnussrdcmBPwc0LL3UyIKSUGtRMkRL2ibhT93xlC0xCHEQ/132, createdBy=e0621689620, createdName=1de55003m82(暂无匿称), createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

文章类型和选刊有关系吗？

38 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1203667, encodeId=13d1120366e80, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：太慢了。。。一月投稿，至今仍under review，关键系统日期都不变，感觉编辑没在处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58b11674643, createdName=johnhesion, createdTime=Fri Mar 18 07:11:00 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197349, encodeId=5ff7119e34928, content=偏重的研究方向：肿瘤 经验分享：2个多月了，一点动静都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Fri Feb 25 23:21:33 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197326, encodeId=25b6119e32619, content=偏重的研究方向：肿瘤 经验分享：审了快四个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ea93125652, createdName=zzk411, createdTime=Fri Feb 25 22:33:56 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091139, encodeId=fe8b109113943, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091140, encodeId=1574109114096, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009564, encodeId=613710095649e, content=审稿速度:12.0 偏重的研究方向：肿瘤 经验分享：2月16号投稿，6月9号给了一个小修，一个月返修时间。7月5号返修回去，截止到8月19号还是under review.真是慢啊。写了撤稿信，3天了都没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Thu Aug 19 22:14:01 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907652, encodeId=9d7190e652db, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;分子 经验分享：一篇肿瘤相关的miRNA文章，审稿了三个多月悲剧了。。。。貌似不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sun Dec 13 19:20:14 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577096, encodeId=f3ae5e7096dc, content=接收个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLwp1gIfBxH4RibdfveKfd9bff6pU7YZXorDEZ0CJXQOZajYCFzibSNQLnUyDqcTiad7e7QAia6TP2w0A/132, createdBy=1f9d2516382, createdName=124cd967m46(暂无昵称), createdTime=Sun Sep 29 10:57:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572459, encodeId=bb8b5e2459fd, content=***pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, beContent=pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f06f5081805, createdName=绝处逢生, createdTime=Thu Jun 20 00:00:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560632, encodeId=723b56063216, content=现在快了吗啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, beContent=啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9cpyAQZ4bhibVic2UeLIE6m8wtDWI93EYnussrdcmBPwc0LL3UyIKSUGtRMkRL2ibhT93xlC0xCHEQ/132, createdBy=e0621689620, createdName=1de55003m82(暂无匿称), createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]

2021-12-28 rayms

选刊时选择几个比较合适？

1 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1203667, encodeId=13d1120366e80, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：太慢了。。。一月投稿，至今仍under review，关键系统日期都不变，感觉编辑没在处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58b11674643, createdName=johnhesion, createdTime=Fri Mar 18 07:11:00 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197349, encodeId=5ff7119e34928, content=偏重的研究方向：肿瘤 经验分享：2个多月了，一点动静都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Fri Feb 25 23:21:33 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197326, encodeId=25b6119e32619, content=偏重的研究方向：肿瘤 经验分享：审了快四个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ea93125652, createdName=zzk411, createdTime=Fri Feb 25 22:33:56 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091139, encodeId=fe8b109113943, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091140, encodeId=1574109114096, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009564, encodeId=613710095649e, content=审稿速度:12.0 偏重的研究方向：肿瘤 经验分享：2月16号投稿，6月9号给了一个小修，一个月返修时间。7月5号返修回去，截止到8月19号还是under review.真是慢啊。写了撤稿信，3天了都没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Thu Aug 19 22:14:01 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907652, encodeId=9d7190e652db, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;分子 经验分享：一篇肿瘤相关的miRNA文章，审稿了三个多月悲剧了。。。。貌似不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sun Dec 13 19:20:14 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577096, encodeId=f3ae5e7096dc, content=接收个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLwp1gIfBxH4RibdfveKfd9bff6pU7YZXorDEZ0CJXQOZajYCFzibSNQLnUyDqcTiad7e7QAia6TP2w0A/132, createdBy=1f9d2516382, createdName=124cd967m46(暂无昵称), createdTime=Sun Sep 29 10:57:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572459, encodeId=bb8b5e2459fd, content=***pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, beContent=pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f06f5081805, createdName=绝处逢生, createdTime=Thu Jun 20 00:00:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560632, encodeId=723b56063216, content=现在快了吗啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, beContent=啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9cpyAQZ4bhibVic2UeLIE6m8wtDWI93EYnussrdcmBPwc0LL3UyIKSUGtRMkRL2ibhT93xlC0xCHEQ/132, createdBy=e0621689620, createdName=1de55003m82(暂无匿称), createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]

2021-08-19 医者阿杜

审稿速度:12.0
偏重的研究方向：肿瘤
经验分享：2月16号投稿，6月9号给了一个小修，一个月返修时间。7月5号返修回去，截止到8月19号还是under review.真是慢啊。写了撤稿信，3天了都没回复。

45 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1203667, encodeId=13d1120366e80, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：太慢了。。。一月投稿，至今仍under review，关键系统日期都不变，感觉编辑没在处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58b11674643, createdName=johnhesion, createdTime=Fri Mar 18 07:11:00 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197349, encodeId=5ff7119e34928, content=偏重的研究方向：肿瘤 经验分享：2个多月了，一点动静都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Fri Feb 25 23:21:33 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197326, encodeId=25b6119e32619, content=偏重的研究方向：肿瘤 经验分享：审了快四个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ea93125652, createdName=zzk411, createdTime=Fri Feb 25 22:33:56 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091139, encodeId=fe8b109113943, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091140, encodeId=1574109114096, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009564, encodeId=613710095649e, content=审稿速度:12.0 偏重的研究方向：肿瘤 经验分享：2月16号投稿，6月9号给了一个小修，一个月返修时间。7月5号返修回去，截止到8月19号还是under review.真是慢啊。写了撤稿信，3天了都没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Thu Aug 19 22:14:01 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907652, encodeId=9d7190e652db, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;分子 经验分享：一篇肿瘤相关的miRNA文章，审稿了三个多月悲剧了。。。。貌似不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sun Dec 13 19:20:14 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577096, encodeId=f3ae5e7096dc, content=接收个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLwp1gIfBxH4RibdfveKfd9bff6pU7YZXorDEZ0CJXQOZajYCFzibSNQLnUyDqcTiad7e7QAia6TP2w0A/132, createdBy=1f9d2516382, createdName=124cd967m46(暂无昵称), createdTime=Sun Sep 29 10:57:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572459, encodeId=bb8b5e2459fd, content=***pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, beContent=pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f06f5081805, createdName=绝处逢生, createdTime=Thu Jun 20 00:00:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560632, encodeId=723b56063216, content=现在快了吗啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, beContent=啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9cpyAQZ4bhibVic2UeLIE6m8wtDWI93EYnussrdcmBPwc0LL3UyIKSUGtRMkRL2ibhT93xlC0xCHEQ/132, createdBy=e0621689620, createdName=1de55003m82(暂无匿称), createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]

2020-12-13 sunrise19890224

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤;分子
经验分享：一篇肿瘤相关的miRNA文章，审稿了三个多月悲剧了。。。。貌似不容易中

110 0

[GetPortalCommentsPageByObjectIdResponse(id=1203667, encodeId=13d1120366e80, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：太慢了。。。一月投稿，至今仍under review，关键系统日期都不变，感觉编辑没在处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58b11674643, createdName=johnhesion, createdTime=Fri Mar 18 07:11:00 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197349, encodeId=5ff7119e34928, content=偏重的研究方向：肿瘤 经验分享：2个多月了，一点动静都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Fri Feb 25 23:21:33 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197326, encodeId=25b6119e32619, content=偏重的研究方向：肿瘤 经验分享：审了快四个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ea93125652, createdName=zzk411, createdTime=Fri Feb 25 22:33:56 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091139, encodeId=fe8b109113943, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091140, encodeId=1574109114096, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009564, encodeId=613710095649e, content=审稿速度:12.0 偏重的研究方向：肿瘤 经验分享：2月16号投稿，6月9号给了一个小修，一个月返修时间。7月5号返修回去，截止到8月19号还是under review.真是慢啊。写了撤稿信，3天了都没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Thu Aug 19 22:14:01 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907652, encodeId=9d7190e652db, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;分子 经验分享：一篇肿瘤相关的miRNA文章，审稿了三个多月悲剧了。。。。貌似不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sun Dec 13 19:20:14 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577096, encodeId=f3ae5e7096dc, content=接收个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLwp1gIfBxH4RibdfveKfd9bff6pU7YZXorDEZ0CJXQOZajYCFzibSNQLnUyDqcTiad7e7QAia6TP2w0A/132, createdBy=1f9d2516382, createdName=124cd967m46(暂无昵称), createdTime=Sun Sep 29 10:57:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572459, encodeId=bb8b5e2459fd, content=***pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, beContent=pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f06f5081805, createdName=绝处逢生, createdTime=Thu Jun 20 00:00:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560632, encodeId=723b56063216, content=现在快了吗啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, beContent=啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9cpyAQZ4bhibVic2UeLIE6m8wtDWI93EYnussrdcmBPwc0LL3UyIKSUGtRMkRL2ibhT93xlC0xCHEQ/132, createdBy=e0621689620, createdName=1de55003m82(暂无匿称), createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]

2019-09-29 124cd967m46(暂无昵称)

接收个案报道吗？

140 0

[GetPortalCommentsPageByObjectIdResponse(id=1203667, encodeId=13d1120366e80, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：太慢了。。。一月投稿，至今仍under review，关键系统日期都不变，感觉编辑没在处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58b11674643, createdName=johnhesion, createdTime=Fri Mar 18 07:11:00 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197349, encodeId=5ff7119e34928, content=偏重的研究方向：肿瘤 经验分享：2个多月了，一点动静都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Fri Feb 25 23:21:33 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197326, encodeId=25b6119e32619, content=偏重的研究方向：肿瘤 经验分享：审了快四个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ea93125652, createdName=zzk411, createdTime=Fri Feb 25 22:33:56 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091139, encodeId=fe8b109113943, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091140, encodeId=1574109114096, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009564, encodeId=613710095649e, content=审稿速度:12.0 偏重的研究方向：肿瘤 经验分享：2月16号投稿，6月9号给了一个小修，一个月返修时间。7月5号返修回去，截止到8月19号还是under review.真是慢啊。写了撤稿信，3天了都没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Thu Aug 19 22:14:01 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907652, encodeId=9d7190e652db, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;分子 经验分享：一篇肿瘤相关的miRNA文章，审稿了三个多月悲剧了。。。。貌似不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sun Dec 13 19:20:14 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577096, encodeId=f3ae5e7096dc, content=接收个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLwp1gIfBxH4RibdfveKfd9bff6pU7YZXorDEZ0CJXQOZajYCFzibSNQLnUyDqcTiad7e7QAia6TP2w0A/132, createdBy=1f9d2516382, createdName=124cd967m46(暂无昵称), createdTime=Sun Sep 29 10:57:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572459, encodeId=bb8b5e2459fd, content=***pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, beContent=pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f06f5081805, createdName=绝处逢生, createdTime=Thu Jun 20 00:00:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560632, encodeId=723b56063216, content=现在快了吗啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, beContent=啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9cpyAQZ4bhibVic2UeLIE6m8wtDWI93EYnussrdcmBPwc0LL3UyIKSUGtRMkRL2ibhT93xlC0xCHEQ/132, createdBy=e0621689620, createdName=1de55003m82(暂无匿称), createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]

2019-06-20 绝处逢生

***pangxiaozi 2016-03-22 15:53:00 发表:
这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。

pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。

148 0

[GetPortalCommentsPageByObjectIdResponse(id=1203667, encodeId=13d1120366e80, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：太慢了。。。一月投稿，至今仍under review，关键系统日期都不变，感觉编辑没在处理稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=58b11674643, createdName=johnhesion, createdTime=Fri Mar 18 07:11:00 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197349, encodeId=5ff7119e34928, content=偏重的研究方向：肿瘤 经验分享：2个多月了，一点动静都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ef12114541, createdName=1891f95b28m, createdTime=Fri Feb 25 23:21:33 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197326, encodeId=25b6119e32619, content=偏重的研究方向：肿瘤 经验分享：审了快四个月了，还在under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ea93125652, createdName=zzk411, createdTime=Fri Feb 25 22:33:56 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091139, encodeId=fe8b109113943, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091140, encodeId=1574109114096, content=选刊时选择几个比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009564, encodeId=613710095649e, content=审稿速度:12.0 偏重的研究方向：肿瘤 经验分享：2月16号投稿，6月9号给了一个小修，一个月返修时间。7月5号返修回去，截止到8月19号还是under review.真是慢啊。写了撤稿信，3天了都没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/01/aaf2cb08ea1e5b19ecba18fb157ba13f.jpg, createdBy=77e72288365, createdName=医者阿杜, createdTime=Thu Aug 19 22:14:01 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907652, encodeId=9d7190e652db, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;分子 经验分享：一篇肿瘤相关的miRNA文章，审稿了三个多月悲剧了。。。。貌似不容易中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=339e1959506, createdName=sunrise19890224, createdTime=Sun Dec 13 19:20:14 CST 2020, time=2020-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577096, encodeId=f3ae5e7096dc, content=接收个案报道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLwp1gIfBxH4RibdfveKfd9bff6pU7YZXorDEZ0CJXQOZajYCFzibSNQLnUyDqcTiad7e7QAia6TP2w0A/132, createdBy=1f9d2516382, createdName=124cd967m46(暂无昵称), createdTime=Sun Sep 29 10:57:00 CST 2019, time=2019-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572459, encodeId=bb8b5e2459fd, content=***pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, beContent=pangxiaozi 2016-03-22 15:53:00 发表: 这个杂志审稿速度确实慢，而且没有投稿系统，查询不到文章的状态。我的第一篇文章就投的这里，一审接近三个月，提了几个修改意见后拒稿。半个月后修改重投，又是接近三个月杳无音讯，本来已经放弃了。还好16年2月份发邮件询问编辑，编辑说文章可以接收，当时那个兴奋，三月初接到版面费发票，3月21号正式接收。前后历时接近8个月，但是结果还是好的，感觉编辑人不错。只是写下自己的经历，希望能够帮助准备投稿的战友们，着急毕业的同学们就不要投了，会等到花儿都谢的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f06f5081805, createdName=绝处逢生, createdTime=Thu Jun 20 00:00:00 CST 2019, time=2019-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560632, encodeId=723b56063216, content=现在快了吗啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, beContent=啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ9cpyAQZ4bhibVic2UeLIE6m8wtDWI93EYnussrdcmBPwc0LL3UyIKSUGtRMkRL2ibhT93xlC0xCHEQ/132, createdBy=e0621689620, createdName=1de55003m82(暂无匿称), createdTime=Sat Sep 01 00:00:00 CST 2018, time=2018-09-01, status=1, ipAttribution=)]

2018-09-01 1de55003m82(暂无匿称)

现在快了吗啦你 2018-04-09 19:24:00 发表:
现在杂志有审稿系统了，审稿速度还可以，可以投试试

啦你 2018-04-09 19:24:00 发表: 现在杂志有审稿系统了，审稿速度还可以，可以投试试

243 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务